quinoxalines has been researched along with Iron Overload in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Feng, M; Liu, T; Wan, L; Yao, W; Zhang, B; Zhang, C; Zhang, Y | 1 |
| An, H; Bao, Y; Huang, D; Shen, N; Wang, K; Yang, J; Yu, F; Zeng, X; Zheng, L; Zhou, W | 1 |
2 other study(ies) available for quinoxalines and Iron Overload
| Article | Year |
|---|---|
Liproxstatin-1 Attenuates Morphine Tolerance through Inhibiting Spinal Ferroptosis-like Cell Death.
Topics: Animals; Cation Transport Proteins; Cyclooxygenase 2; Drug Tolerance; Ferroptosis; Gene Expression Regulation; Hyperalgesia; Inflammation; Iron; Iron Overload; Lipid Peroxidation; Malondialdehyde; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitochondria; Morphine; Neurons; Nociception; Oxidative Stress; Phospholipid Hydroperoxide Glutathione Peroxidase; Quinoxalines; Random Allocation; Reactive Oxygen Species; Receptors, Transferrin; Spinal Cord; Spiro Compounds; Superoxide Dismutase | 2019 |
Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Deferoxamine; Dopaminergic Neurons; Ferric Compounds; Ferroptosis; Humans; Iron Chelating Agents; Iron Overload; Nerve Growth Factor; Neuroprotective Agents; Parkinson Disease, Secondary; Quaternary Ammonium Compounds; Quinoxalines; Rats; Reactive Oxygen Species; Spiro Compounds | 2021 |